April 13, 2026

Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness

Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment

The Analytical Scientist

April 07, 2026

Cancer Is Coming for Younger Adults — and the Field Isn’t Ready

The epidemiological tools built for midlife disease are straining to explain a generational shift

Conexiant

April 06, 2026

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Conexiant

April 03, 2026

Was the GLP-1 Problem Always Cost?

A JAMA Viewpoint argues the BALANCE model targets the leading cause of discontinuation.

Conexiant

March 26, 2026

Obesity’s Cancer Role Underestimated

A proposed framework highlights potential sources of bias in current estimates

Conexiant

March 20, 2026

Obesity Care Lags Behind Advances in Treatment

A 2026 expert perspective highlights system-level gaps in care delivery

Conexiant

March 12, 2026

The New Blueprint for Vaccine Development

ReiThera’s leaders discuss platform technologies, scalable manufacturing, and the trust needed to strengthen global vaccine preparedness

The Medicine Maker

February 24, 2026

What Is Causing a Rise in Early-Onset Gastrointestinal Cancers, Including Pancreatic Cancer?

Although it’s been widely reported for years that colorectal cancer incidence has been increasing among younger adults under age 50 by between 1% and 2% annually since the mid-1990s,1 two new studies ...

The ASCO Post

February 16, 2026

Why AI, Cloud & Sustainability Strategies May Collide 

UK pharma’s digital ambition is starting to work against it, writes Martyn Williams of COPA-DATA UK

The Medicine Maker

February 10, 2026

Electronic Lab Notebooks Are Failing Scientists and Inflating R&D Costs

New survey finds outdated lab software is driving experiment duplication, workflow bottlenecks, and risky shadow AI use

The Medicine Maker